Clinical Trial Update: Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures [Phase 3]

View source ↗

Summary

Phase 3 trial update for pregabalin monotherapy in partial seizures (epilepsies, partial) has been terminated; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial Epilepsy

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Epilepsies, Partial | Phase 3 | Status: TERMINATED | Results posted: 2012-05-10